how do I know if my son is a candidate?
--- In MyelinSheathProtein@yahoogroups.com, Zurama
<autismtookmickie@...> wrote:
>
> I didn't know there was a list. How do I get Mickie on that list. Are
your
> boys on it?
>
> Zury
>
> On Fri, Jan 23, 2009 at 9:21 AM, Gabriela DeVelbiss <
> gabrieladevelbiss@... wrote:
>
> > http://news.bbc.co.uk/2/hi/health/7847450.stm
> >
> >
> > Green light for US stem cell work
> > Advertisement
> >
> > Fergus Walsh explains why the trial is significant
> >
> > *US regulators have cleared the way for the world's first study on
human
> > embryonic stem cell therapy.*
> > The US Food and Drug Administration have been considering the 21,000
page
> > application for months. The decision by the FDA to give the go-ahead
comes
> > at a symbolic moment, just days after the inauguration of President
Barack
> > Obama. Since 2001 there have been limits on federal funding for
embryonic
> > stem cell research. The decision of the FDA is independent of White
House
> > control, but the new president is widely expected to adopt a more
pragmatic
> > and science-oriented approach to stem cell research. *The knowledge
> > that will be gained in this first clinical trial deploying embryonic
stem
> > cell derived material will accelerate the development of all future
stem
> > cell therapies*
> > Professor Chris Mason, University College London
> > Under President Bush, federal funding had been limited to around 60
stem
> > cell lines created from embryos destroyed prior to August 2001.
Scientists
> > had warned that only 20 eligible cell lines remained useful for
research and
> > many of these were problematic. Researchers had told the BBC that
the
> > restrictions had slowed down their work. *Controversy* Geron Corp,
the
> > company behind the research, plans to initiate a clinical trial in a
handful
> > of patients paralysed due to spinal cord injury. Interest in use of
> > embryonic stem cells is due to their ability to turn into any of the
body's
> > 200 cell types. Using embryos donated through IVF treatment
scientists
> > have coaxed the stem cells inside into many types of tissue. One
embryo can
> > provide a limitless supply because the cell lines can be grown
indefinitely.
> > But the use of human embryonic stem cells in research is
controversial with
> > some campaigners saying it is unethical. Geron, a biotech company
based in
> > "silicon valley" south of San Francisco, has spent $170m on
developing a
> > stem cell treatment for spinal cord injury. The research will use
cells
> > coaxed to become nerve cells which are injected into the spinal
cord. In
> > animal trials of the treatment, paralysed rats regained some
movement. Company
> > chief Dr Tom Okarma said: "What stem cells promise for a heart
attack or
> > spinal cord injury or diabetes is that you go to the hospital, you
receive
> > these cells and you go home with a repaired organ, that has been
repaired by
> > new heart cells or new new nerve cells or new islet cells that have
been
> > made from embryonic stem cells." *'Pivotal decision'* Professor
Chris
> > Mason, an expert in regenerative medicine at University College
London,
> > described the FSA decision as "historic" and a "pivotal milestone in
the
> > development of embryonic stem cell therapies. He said: "The
knowledge that
> > will be gained in this first clinical trial deploying embryonic stem
cell
> > derived material will accelerate the development of all future stem
cell
> > therapies." Professor Pete Coffey, director of the London Project to
cure
> > blindness, said: "It's great news for the field. "This strengthens
our
> > recent call for regulators in the UK to help provide a clear process
for
> > researchers to take this forward. "It's also exciting for me because
it
> > brings our own moves towards clinical trials with embryonic stem
cells for
> > age-related macular degeneration a step forward." Professor Robin
> > Lovell-Badge, head the MRC National Institute for Medical Research,
said it
> > often took 15 to 20 years to develop a therapy. "It takes a long
time and
> > much work to derive processes that will efficiently and reproducibly
give an
> > appropriate cell type for grafting and many animal experiments to
test
> > efficacy and safety. "An appropriate set of patients have to be
identified
> > for the first tests and clinicians willing to participate in trials.
"And
> > the regulatory hurdle is, understandably, a huge one - in this case
it
> > required 21,000 pages of documents." He added that for those
patients
> > desperate for treatment, and for their families, the news showed the
> > research is moving in the right direction.
> >
> > Love, Gabby. :*0**)*
> >
*http://stemcellforautism.blogspot.com/*<http://stemcellforautism.blogsp\
ot.com/>
> >
> > "I know of nobody who is purely Autistic or purely neurotypical.
Even God
> > had some Autistic moments, which is why the planets all spin." ~
Jerry
> > Newport
> >
> >
> >
> >
> >
>
>
>
> --
> Zurama
> http://parentsagainstautism.ning.com/
> http://mickiesprogress.blogspot.com
> http://autismoporinyeccion.blogspot.com
> http://www.zurama.com
>